NanoViricides, Inc. (NASDAQ:NNVC)

PRESS RELEASE

published on 11/10/2025 at 14:30, 2 months 21 days ago

NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo
NanoViricides, Inc. receives approval to start Phase II Clinical Trial of NV-387 for MPox treatment in the DRC. NV-387 shows promise as a broad-spectrum antiviral drug

NanoViricides NV-387 Phase II Clinical Trial Broad-spectrum Antiviral MPOX Treatment
BRIEF

published on 11/05/2025 at 14:35, 2 months 26 days ago

NanoViricides se prépare à une assemblée générale cruciale de ses actionnaires dans un contexte de préoccupations croissantes liées au MPox

NanoViricides NV-387 Essais Cliniques Médicaments Antiviraux Mpox
BRIEF

published on 11/05/2025 at 14:35, 2 months 26 days ago

NanoViricides Prepares for Critical Shareholders Meeting Amidst Rising MPox Concerns

NanoViricides NV-387 Clinical Trials Antiviral Drugs Mpox
PRESS RELEASE

published on 11/05/2025 at 14:30, 2 months 26 days ago

NanoViricides Annual Shareholders Meeting to be Held at 10 am on Saturday, November 5th at on Saturday, November 8, 2025, at the Hampton Inn & Suites Stamford, CT
NanoViricides, Inc. announces Annual Shareholders Meeting to discuss progress on NV-387, a potential treatment for MPox Clade I. Clinical trials underway

NV-387 Clinical Trials NanoViricides Inc. Annual Shareholders Meeting Mpox Clade I
BRIEF

published on 11/03/2025 at 14:35, 2 months 28 days ago

NanoViricides présentera ses produits à la conférence des investisseurs de Spartan Capital en 2025.

NanoViricides NV-387 Essais Cliniques Médicaments Antiviraux Conférence De La Capitale Spartiate
BRIEF

published on 11/03/2025 at 14:35, 2 months 28 days ago

NanoViricides to Present at Spartan Capital Investor Conference 2025

NanoViricides NV-387 Clinical Trials Antiviral Drugs Spartan Capital Conference
PRESS RELEASE

published on 11/03/2025 at 14:30, 2 months 28 days ago

NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd
NanoViricides, Inc. to present groundbreaking antiviral drug NV-387 at Spartan Capital Investor Conference. CEO Diwan to update on drug pipeline & Platform Technologies for licensing

NanoViricides NV-387 Clinical Trial Antiviral Drug Spartan Capital Investor Conference
BRIEF

published on 10/29/2025 at 13:50, 3 months 3 days ago

NV-387 : un agent antiviral prometteur contre la rougeole

NanoViricides NV-387 Essais Cliniques Recherche Antivirale Traitement De La Rougeole
BRIEF

published on 10/29/2025 at 13:50, 3 months 3 days ago

NV-387: A Promising Antiviral Agent for Measles

NanoViricides NV-387 Clinical Trials Antiviral Research Measles Treatment
PRESS RELEASE

published on 10/29/2025 at 13:45, 3 months 3 days ago

Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive
NanoViricides, Inc. announced progress in antiviral research with their drug NV-387 showing potent activity against Measles virus. Clinical trials have shown safety and effectiveness, positioning for emergency use

NanoViricides NV-387 Clinical Trials Antiviral Research Measles Virus

Published on 01/31/2026 at 03:15, 1 day 11 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 12 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 13 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 15 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 16 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 23 hours 17 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 2 hours ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 12 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 17 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 19 hours ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 20 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 21 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 21 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 21 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 6 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News